[1] 吴静, 沈慧聪. 磁共振弥散张量成像在高级别胶质瘤患者预后评估中的应用价值[J]. 医学影像学杂志, 2019,29(10):1652-1655. [2] Aliotta E, Batchala P P, Schiff D, et al. Increased intratumoral infiltration in IDH wild-type lower-grade gliomas observed with diffusion tensor imaging[J]. Journal of Neuro-Oncology, 2019,145(26):123-128. [3] 中国华人民共和国卫生部. 中国常见恶性肿瘤诊治规范[M]. 北京:北京医科大学、中国协和医科大学联合出版社, 1991. [4] Armstrong T S, Vera-Bolanos E, Gning I, et al. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients[J]. Cancer, 2011,117(14):3222-3228. [5] Christopher M, Erjon A, Su Z, et al. Quantitative diffusion tensor imaging (DTI) analysis reveals different infiltrative patterns of oligodendrogliomas and astrocytomas in Peri-Tumour white matter[J]. Neurosurgery, 2019(5):5. [6] 黄干, 姚旭峰, 于同刚, 等. 基于弥散张量成像的脑结构网络增龄性变化研究[J]. 医学影像学杂志, 2019,29(9):1441-1445. [7] Park C J, Choi Y S, Park Y W, et al. Diffusion tensor imaging radiomics in lower-grade glioma:Improving subtyping of isocitrate dehydrogenase mutation status[J]. Neuroradiology, 2020,62(3):319-326. [8] 肖雄, 孔鲁, 泮长存, 等. 弥散张量成像在脑干胶质瘤手术治疗中的应用价值[J]. 中华神经外科杂志, 2019,35(8):817-822. [9] Hanlon C A, Lench D H, Dowdle L T, et al. Neural architecture influences repetitive transcranial magnetic stimulation-induced functional change:A diffusion tensor imaging and functional magnetic resonance imaging study of cue-reactivity modulation in alcohol users[J]. Clinical Pharmacology & Therapeutics, 2019,106(4):702-705. [10] 王向东, 王引言, 江涛. 磁共振弥散张量成像在岛叶胶质瘤诊疗中的应用进展[J]. 中华神经外科杂志, 2020,36(3):307-309. [11] Liang S G, Wang Q, Kong X Z, et al. White matter abnormalities in major depression biotypes identified by diffusion tensor imaging[J]. Neuroscience Bulletin, 2019,35(5):867-876. [12] 张玉柱, 李林, 李大鹏, 等. 磁共振DTI技术定量参数在脑淋巴瘤与高级别胶质瘤鉴别中的应用[J]. 医学影像学杂志, 2019,29(12):2019-2022. |